The exact mechanisms by which anti-SOX1 antibodies exert their effects are not completely understood; however, they are thought to be associated with cancers, especially small-cell lung cancer (SCLC), which is the tumor type most often found in patients with paraneoplastic neurological syndromes (25, 26). Here, SOX1 is linked to paraneoplastic neurologic syndrome.